Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CRADD Antikörper (AA 1-199)

CRADD Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal 23# unconjugated
Produktnummer ABIN7426616
  • Target Alle CRADD Antikörper anzeigen
    CRADD (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
    Bindungsspezifität
    • 15
    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-199
    Reaktivität
    • 47
    • 5
    • 2
    Human
    Wirt
    • 43
    • 4
    • 1
    • 1
    Maus
    Klonalität
    • 42
    • 7
    Monoklonal
    Konjugat
    • 29
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CRADD Antikörper ist unkonjugiert
    Applikation
    • 38
    • 21
    • 8
    • 8
    • 7
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Monoclonal Antibody to CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD)
    Spezifität
    The antibody is a mouse monoclonal antibody raised against CRADD. It has been selected for its ability to recognize CRADD in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Maus, Ratte
    Aufreinigung
    Protein A + Protein G affinity chromatography
    Immunogen
    Recombinant CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD) corresdonding to Met1~Glu199 (Accession # P78560) with N-terminal His Tag
    Klon
    23#
    Isotyp
    IgG2b kappa
    Top Product
    Discover our top product CRADD Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-5 μg/mL Immunocytochemistry in formalin fixed cells: 5-30 μg/mL Immunohistochemistry in formalin fixed frozen section: 5-30 μg/mL Immunohistochemistry in paraffin section: 5-30 μg/mL Enzyme-linked Immunosorbent Assay: 0.05-2 μg/mL Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    CRADD (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
    Andere Bezeichnung
    CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD Produkte)
    Synonyme
    cradd antikoerper, MGC89035 antikoerper, zgc:101717 antikoerper, CRADD antikoerper, DKFZp468A2219 antikoerper, LOC100226369 antikoerper, raidd antikoerper, MGC78788 antikoerper, MRT34 antikoerper, RAIDD antikoerper, CASP2 and RIPK1 domain containing adaptor with death domain antikoerper, CASP2 and RIPK1 domain containing adaptor with death, gene 1 antikoerper, CASP2 and RIPK1 domain containing adaptor with death, gene 2 S homeolog antikoerper, CRADD antikoerper, cradd.1 antikoerper, cradd antikoerper, cradd.2.S antikoerper, Cradd antikoerper
    Hintergrund
    RAIDD, RIP-Associated ICH1/CED3-Homologous Protein With Death Domain, Caspase and RIP adapter with death domain, Death domain-containing protein CRADD
    Pathways
    Apoptose, Caspase Kaskade in der Apoptose, Positive Regulation of Endopeptidase Activity
Sie sind hier:
Kundenservice